|
GRLF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
8.02513611120048E-12 |
| Normal-vs-Stage3 |
8.00949999657519E-08 |
| Normal-vs-Stage4 |
4.3737000021693E-08 |
| Stage1-vs-Stage2 |
8.191400E-01 |
| Stage1-vs-Stage3 |
3.451600E-01 |
| Stage1-vs-Stage4 |
8.406000E-01 |
| Stage2-vs-Stage3 |
3.799800E-01 |
| Stage2-vs-Stage4 |
9.728000E-01 |
| Stage3-vs-Stage4 |
5.317400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77555756156289E-15 |
| Normal-vs-AfricanAmerican |
1.94289029309402E-14 |
| Normal-vs-Asian |
2.09640000004008E-06 |
| Caucasian-vs-AfricanAmerican |
9.700600E-01 |
| Caucasian-vs-Asian |
6.957600E-01 |
| AfricanAmerican-vs-Asian |
6.611600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.46480003074367E-09 |
| Male-vs-Female |
6.19649999999972E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.64089910734833E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.43920447676282E-11 |
| Normal-vs-Extreme_Obese |
2.47079999793343E-08 |
| Normal_Weight-vs-Extreme_Weight |
8.713800E-02 |
| Normal_Weight-vs-Obese |
4.878000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.781600E-01 |
| Extreme_Weight-vs-Obese |
3.682600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.723600E-01 |
| Obese-vs-Extreme_Obese |
3.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.541220E-03 |
| Normal-vs-Age(41-60Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.44050010703256E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.685360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.568300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.092800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.966960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.739000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.685400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
8.58124682423522E-12 |
| Normal-VS-KIRP CIMP |
1.521790E-01 |
| Normal-VS-Unclassified PRCC |
4.54250004278123E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.060270E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.953500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.416400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.391800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.028000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.580400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.43019999996075E-06 |
| Normal-vs-N2 |
7.181000E-04 |
| N0-vs-N1 |
3.427800E-02 |
| N0-vs-N2 |
3.695600E-01 |
| N1-vs-N2 |
7.438200E-01 |
|
|
